PT Darma Henwa Tbk (IDX:DEWA)

CTI BioPharma Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,032,610	2,425,764	1,311,224	1,158,248	1,092,687	1,092,687
Market Cap Growth	213.26%	85.00%	13.21%	6.00%	-	-
Enterprise Value	11,501,339	3,202,366	2,464,146	1,888,761	2,187,800	2,312,633
Last Close Price	222.00	111.00	60.00	53.00	50.00	50.00
PE Ratio	76.34	148.50	37.15	-	70.58	47.84
PS Ratio	1.47	0.40	0.18	0.19	0.24	0.26
PB Ratio	1.89	0.73	0.40	0.36	0.28	0.29
P/TBV Ratio	1.89	0.73	0.40	0.36	0.28	0.29
P/FCF Ratio	-	-	1.42	555.60	1.49	4.33
P/OCF Ratio	10.05	3.96	1.18	4.75	1.14	1.87
EV/Sales Ratio	1.87	0.53	0.33	0.31	0.48	0.55
EV/EBITDA Ratio	11.39	4.37	2.74	3.89	2.38	4.88
EV/EBIT Ratio	43.58	22.96	12.47	-	6.92	-
EV/FCF Ratio	-8.45	-	2.67	906.02	2.98	9.17
Debt / Equity Ratio	0.61	0.77	0.43	0.64	0.47	0.39
Debt / EBITDA Ratio	2.91	2.94	1.31	2.22	1.67	2.54
Debt / FCF Ratio	-	-	1.53	988.26	2.48	5.74
Asset Turnover	0.70	0.71	0.91	0.73	0.58	0.55
Inventory Turnover	13.31	13.83	14.12	13.65	14.68	11.87
Quick Ratio	0.75	0.55	0.52	0.33	0.41	0.39
Current Ratio	1.05	0.76	0.69	0.60	0.82	1.12
Return on Equity (ROE)	1.91%	0.50%	1.08%	-6.69%	0.40%	0.65%
Return on Assets (ROA)	1.87%	1.03%	1.53%	-1.70%	2.49%	-0.37%
Return on Capital (ROIC)	2.66%	1.65%	2.47%	-2.48%	3.59%	-0.56%
Return on Capital Employed (ROCE)	3.80%	2.70%	5.00%	-	6.10%	-
Earnings Yield	0.86%	0.67%	2.69%	-21.48%	1.42%	2.09%
FCF Yield	-15.06%	-33.91%	70.40%	0.18%	67.18%	23.08%

Updated Dec 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.